#clinical-trials
Read more stories on Hashnode
Articles with this tag
Talquetamab (tal) is the first bispecific antibody targeting the novel antigen, GPRC5D, approved in the US andEU for treatment of patients (pts) with...
The aim of this proposal is to identify immune biomarkers, genetic risk, and the clinical consequences of low count monoclonal B-cell lymphocytosis...